Jennison Associates’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Jennison Associates’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-11,116	Closed	-$583K	–	732
2020 Q3	$583K	Sell	11,116 -595,778	-98%	-$24.7M	﹤0.01%	601
2020 Q2	$20.2M	Buy	606,894 +3,198	+0.5%	+$102K	0.02%	294
2020 Q1	$16.4M	Buy	603,696 +3,696	+0.6%	+$103K	0.02%	282
2019 Q4	$11.8M	Buy	+600,000	New	+$9.59M	0.01%	366

Jennison Associates's MNTA Position: Q4 2020 in Review

Jennison Associates sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 11,116 shares — an estimated $583K sold.

Jennison Associates first reported a position in MNTA in Q4 2019 and held it in 4 quarters. The position peaked at $20.2M in Q2 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

Jennison Associates reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
Jennison Associates sold 11,116 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $583K.
Jennison Associates first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2019 and held it in 4 quarters.
Jennison Associates's Momenta Pharmaceuticals, Inc. position peaked at $20.2M in Q2 2020.
0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Jennison Associates's 13F filing for Q4 2020, filed 5 Feb 2021.